Tag: Regeneron Pharmaceuticals
Teva, Regeneron report positive data for fasinumab in phase 3 osteoarthritis trial
Teva Pharmaceutical Industries and Regeneron Pharmaceuticals said that a phase 3 study evaluating nerve growth factor (NGF) antibody fasinumab in patients with chronic pain from ... Read More
Dupixent eczema injection gets FDA approval for atopic dermatitis treatment
Dupixent (dupilumab), the co-developed eczema injection from pharma giants Sanofi and Regeneron Pharmaceuticals, has got the US FDA approval for the treatment of moderate-to-severe atopic ... Read More
Eczema drug Dupixent succeeds in phase 3 atopic dermatitis clinical trial
Atopic dermatitis clinical trial : The jointly developed eczema drug, Dupixent (dupilumab) from Sanofi and Regeneron Pharmaceuticals has met the primary endpoints of a crucial ... Read More